Bruno Vellas
Physiology · 2001–2022
A researcher in the Science corpus: 18 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 133 citations into it; #1,581 of 2,276 by trust here, #330 by citations
- Geriatrics and Gerontology — 33 citations into it; #86 of 114 by trust here, #76 by citations
- Public Health, Environmental and Occupational Health — 7 citations into it; #1,842 of 2,368 by trust here, #1,637 by citations
Whom Bruno Vellas trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Bruno Vellas overall
Papers from Bruno Vellas's perspective
Ordered by how strongly the researchers Bruno Vellas trusts endorse each paper. Same corpus, a different order for every researcher.
- Frailty in older adults: evidence for a phenotype. (The journals of gerontology. Series A, Biological sciences and medical sciences)
- Prognostic impact of disease-related malnutrition. (Clinical Nutrition)
- Management of cancer in the older person: a practical approach. (The Oncologist)
- Overview of the MNA--Its history and challenges. (The Journal of Nutrition, Health & Aging)
- Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. (The journals of gerontology. Series A, Biological sciences and medical sciences)
- Random Forests
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. (Lancet Neurology)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (Nature reviews. Drug discovery)
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease (Nature)
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (Alzheimer's & Dementia)
Their papers
- Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. (2014) — 1,548 citations
- A phase 3 trial of semagacestat for treatment of Alzheimer's disease. (2013) — 1,067 citations
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
- The I.A.N.A. task force on frailty assessment of older people in clinical practice (2008) — 1,044 citations
- Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease (2022) — 1,144 citations
- Lecanemab in Early Alzheimer's Disease. (2022) — 3,696 citations
- Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease (2018) — 862 citations
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. (2014) — 3,079 citations
- Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness (2014) — 296 citations
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease (2014) — 2,688 citations
- Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) International Consensus Group (2013) — 947 citations
- Frequency of Malnutrition in Older Adults: A Multinational Perspective Using the Mini Nutritional Assessment (2010) — 981 citations
- Assessing the nutritional status of the elderly: The Mini Nutritional Assessment as part of the geriatric evaluation. (2009) — 1,559 citations
- Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders (2009) — 611 citations
- Exercise Program for Nursing Home Residents with Alzheimer's Disease: A 1‐Year Randomized, Controlled Trial (2007) — 690 citations
- Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease (2006) — 630 citations
- Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. (2002) — 998 citations
- A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease (2001) — 647 citations